The FDA approved the first oral GLP-1 specifically for weight loss on December 22, 2025
Fewer side effects means better adherence, which means faster results, which means potentially shorter treatment duration and lower total cost
Given the limited efficacy and potential metabolic consequences of brief drug interruptions, discontinuation for 7 days should be restricted to cases of proven preparation failure despite intensified regimens or to those manifesting florid upper gastrointestinal symptoms
Other mechanisms include increased insulin resistance induced by high-dose glucocorticoids that increases intra-portal insulin, decreases IGFBP-1 that increases free IGF-I, and direct glucocorticoid effects in increasing hepatic IGF-I synthesis and decreasing hepatic insulin clearance (105)
Patients without insurance, or without Wegovy coverage through their insurance plan, have access to self-pay medication options like Wegovy ($349/mo.), Zepbound vials (starting at $349/mo.) and more through this program if eligible